Clinical biomarkers in oncology: focus on colorectal cancer.
about
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapyAnticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.Identification of a biomarker panel for colorectal cancer diagnosis.Molecular events in primary and metastatic colorectal carcinoma: a review.The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009)TP53 drives invasion through expression of its Δ133p53β variant.Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.Microfluidic platforms for biomarker analysis.KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas.Targeted imaging of colorectal dysplasia in living mice with fluorescence microendoscopy.Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients: a meta-analysis.A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer.SALL4 as a new biomarker for early colorectal cancers.
P2860
Q34344165-A969BC70-61FE-4191-A22C-7BEF5E8F3472Q35050195-66487F33-ECE2-4255-AA07-7CE774035568Q35584153-B41010DF-1C84-4A1F-8392-2B23D3A9393DQ35773077-29B5B15E-936F-4284-93BE-67E3E1CC6971Q35881028-5587D4C7-C0CF-43B4-9FBD-A247EAA4F910Q35977849-8DB4FFF5-2CF9-4DA2-8B1A-9558E6A51567Q36284222-EBC6E440-14EF-4CF4-98C1-AED62E6E584CQ36563162-ED01E05F-B136-4C7F-9079-C641A6AC4F5BQ36649513-A9A34066-BE2E-4C5E-B8B3-4E03D6970C87Q37344716-E57B9702-65B7-4421-9C81-E40B3511B50BQ37960201-05EA6198-2A2C-4E13-886A-7FDED475A97AQ38198962-A99CE9A0-50AD-4D44-9AEC-B2A175DF720BQ39584798-71CF294E-AFED-48F1-862F-0E341B355E86Q41827923-FF2A47B9-6D33-4807-A0C1-DDC0148B77CFQ42046586-A82AC4DD-4D88-42D9-9626-BB2F72279D3EQ42187007-3F2A8AC5-6546-42AC-9C5C-18276AF74275Q46091563-1A815E9D-99BC-4ED4-9BF4-46ADA53D6CF6Q54193733-BD59182E-3718-46C6-9D7D-69232859AAD0
P2860
Clinical biomarkers in oncology: focus on colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical biomarkers in oncology: focus on colorectal cancer.
@en
Clinical biomarkers in oncology: focus on colorectal cancer.
@nl
type
label
Clinical biomarkers in oncology: focus on colorectal cancer.
@en
Clinical biomarkers in oncology: focus on colorectal cancer.
@nl
prefLabel
Clinical biomarkers in oncology: focus on colorectal cancer.
@en
Clinical biomarkers in oncology: focus on colorectal cancer.
@nl
P2093
P2860
P356
P1476
Clinical biomarkers in oncology: focus on colorectal cancer.
@en
P2093
Bart Biesmans
Jef De Schutter
Wendy De Roock
P2860
P2888
P304
P356
10.1007/BF03256319
P577
2009-01-01T00:00:00Z